CORRECTING and REPLACING: AHF: Pharma Companies Scrapping HIV Diagnostics Endangers Patients

LOS ANGELES–(BUSINESS WIRE)–#HIV–Please replace the release dated May 17, 2023 with the following corrected version due to multiple revisions.

The updated release reads:

AHF: PHARMA COMPANIES SCRAPPING HIV DIAGNOSTICS ENDANGERS PATIENTS

AIDS Healthcare Foundation (AHF) supports an appeal by Médecins Sans Frontières (MSF) urging Abbott Laboratories and Becton Dickinson (BD) to continue production of point-of-care (POC) CD4 machines. Both companies have announced that they will phase out the production of new machines over the coming years, including Abbott’s Pima CD4 analyzers, which AHF widely uses around the world.

“We fully support MSF’s position on this issue. POC CD4 machines are vital to patient care, especially because we are seeing an increase in HIV late presenters across AHF facilities, including people with advanced AIDS; in such cases, baseline CD4 is essential, and if it is available at POC, it is even more effective. The WHO needs to emphasize this fact!” said AHF Senior Global Medical Director Dr. Adele Schwartz Benzaken. “COVID-19 disrupted HIV testing and delayed treatment initiation for HIV positive people. Rapid CD4 testing saves lives by getting people into treatment for opportunistic infections. We urge Abbott and BD not to abandon patients and medical providers who rely on this technology every day.”

About AIDS Healthcare Foundation (AHF)

AIDS Healthcare Foundation, the largest global AIDS organization, currently provides medical care and/or services to over 1.7 million people in 45 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region and Europe. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth and follow us on Twitter: @aidshealthcare and Instagram: @aidshealthcare.

Contacts

US MEDIA CONTACT:

Ged Kenslea, Senior Director, Communications, AHF

+1 323 308 1833 work +1.323.791.5526 mobile

[email protected]

Denys Nazarov, Director of Global Policy & Communications, AHF

+1 323.308.1829

[email protected]

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.